BamSEC and AlphaSense Join Forces
Learn More

NeoGenomics Inc. – Indentures

NASDAQ: NEO    
Share price (7/21/26): $14.45    
Market cap (7/21/26): $1.882 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 132 pages Neogenomics, Inc. and U.S. Bank Trust Company, National Association as Trustee Indenture Dated as of June 22, 2026 0.75% Convertible Senior Notes Due 2032
12/34/56
EX-4.1
from 8-K 106 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of January 11, 2021 0.25% Convertible Senior Notes Due 2028
12/34/56
EX-4.1
from S-3ASR 106 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of January [ ], 2021 [ ]% Convertible Senior Notes Due 2028
12/34/56
EX-4.1
from 8-K 103 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of May 4, 2020 1.25% Convertible Senior Notes Due 2025
12/34/56
EX-4.1
from S-3ASR 103 pages Neogenomics, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of May [●], 2020 [●]% Convertible Senior Notes Due 2025
12/34/56
EX-4.1
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-8 18 pages Neogenomics, Inc. Amended and Restated Equity Incentive Plan Amended and Restated Effective as Of: April 16, 2013 Neogenomics, Inc. Amended and Restated Equity Incentive Plan
12/34/56
EX-4.1
from S-8 10 pages Neogenomics, Inc. Employee Stock Purchase Plan Originally Effective October 31, 2006 as Amended and Restated April 16, 2013
12/34/56
EX-4.2
from 8-K 9 pages Neogenomics, Inc. Equity Incentive Plan Stock Option Agreement
12/34/56
EX-4.1
from 8-K 9 pages Warrant Agreement
12/34/56
EX-4.1
from S-8 ~10 pages 2003 Equity Incentive Plan
12/34/56